Richard A. Edlin - 06 Sep 2022 Form 4 Insider Report for EAGLE PHARMACEUTICALS, INC. (EGRX)

Role
Director
Signature
/s/ Scott Tarriff, Attorney-in-Fact
Issuer symbol
EGRX
Transactions as of
06 Sep 2022
Net transactions value
-$210,732
Form type
4
Filing time
08 Sep 2022, 17:08:57 UTC
Previous filing
02 Mar 2022
Next filing
09 Mar 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction EGRX Common Stock Sale $210,732 -6,800 -23% $30.99 22,600 06 Sep 2022 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.